Global Extracorporeal Membrane Oxygenation Machine Market: Overview

Extracorporeal membrane oxygenation is a machine that helps people with the life risking illness that stops their lungs or heart from working properly. For instance, extracorporeal membrane oxygenation (ECMO) machine is used during life risking indications such as shock after a massive heart attack, or severe lung damage from infection. Extracorporeal membrane oxygenation (ECMO) machine is the replacement for the function of the lungs and heart.

The people who need support from an extracorporeal membrane oxygenation (ECMO) machine are cared in the intensive care unit of the hospitals. Depending on how the condition of the patients’ progresses, the support of extracorporeal membrane oxygenation (ECMO) machine is given for only a few hours to days, but may require it for a few weeks. According to the research report, the global extracorporeal membrane oxygenation machine market was valued at US$487.40 mn by the end of 2025 from US$307.00 mn in 2016. During the forecast years of 2017 and 2025, the global market is expected to surge at a CAGR of 5.4%.

global extracorporeal membrane oxygenation machine market

Respiratory Segment to Soar as Cardiovascular Diseases Continue to be on the Rise

The global extracorporeal membrane oxygenation machine market is classified on the basis of component type, application, modality, and region. Based on the component type, the market is divided into pumps, oxygenators, heat exchangers, saturation monitors, and others. Pumps can further be categorized into roller pumps, and centrifugal pumps. The oxygenators segment held a share of 38.4% in the global market in 2016 in terms of revenue. Growing number of clinical trials and tremendous product innovation is expected to keep this segment at the forefront in the near future.

In terms of application, the market is categorized into cardiology, respiratory, and extracorporeal cardiopulmonary resuscitation. Market study indicates that the respiratory segment is likely to be the key revenue generator in the global market. High prevalence of chronic obstructive pulmonary disease (COPD) in addition to poor lifestyle choices such as consumption of tobacco are expected to drive this segment in the near future. Based on modality, the market has been categorized into venoarterial, venovenous, and arteriovenous. The venovenous segment of the global extracorporeal membrane oxygenation machine held a leading share in the market in 2016 and is expected to continue on the same lines in the forthcoming years.

Asia Pacific expected to Grow Rapidly during Forecast Period with Rising Awareness

In terms of geography, the global extracorporeal membrane oxygenation machine market has been divided into 5 major regions, which are Latin America, Europe, North America, Asia Pacific, and Middle East & Africa. North America dominated the extracorporeal membrane oxygenation (ECMO) machine market in terms of revenue in 2016 and is anticipated to dominate during the forecast period from 2017 to 2025. Better healthcare infrastructure and higher acceptance of technology have fuelled the growth of this regional market in the past few years.

Europe accounts for the second large market share for extracorporeal membrane oxygenation (ECMO) machine market in terms of revenue in 2016 owing to presence of major key players, and high investments in research and developments. Asia Pacific is anticipated to grow fast, due to the increasing promotions and awareness in the region. Latin America is anticipated to grow during the forecast period due to the high prevalence of respiratory diseases in Brazil, increasing private healthcare insurance coverage, increasing investment of key market players are the key driving factors global extracorporeal membrane oxygenation machine market in Latin America. Middle East & Africa is anticipated to grow during the forecast period due to  increasing initiatives by the government for improvement of the health care industry have paved way for advanced medical treatment that has subsequently propelled the market growth in the region.

Key companies profiled in the report include Medtronic plc. Getinge AB, LivaNova PLC. XENIOS AG, EUROSETS, and Hemovent GmbH, Terumo Corporation, and Nipro Corporation.

Global Extracorporeal Membrane Oxygenation Machine Market: Scope and Methodology

This report on the global extracorporeal membrane oxygenation machine market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global extracorporeal membrane oxygenation machine market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global extracorporeal membrane oxygenation machine market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global extracorporeal membrane oxygenation machine market.

Extracorporeal Membrane Oxygenation Machine Market: Segmentation

Extracorporeal membrane oxygenation (ECMO) is a traditional cardiopulmonary procedure that provides support during various types of cardiac and pulmonary surgical procedures. Extracorporeal membrane oxygenation system is used for the patient suffering from heart failure and lung failure. It acts as a cardiac and respiratory support. Effective oxygenation is obtained when oxygen and blood are running in opposite direction through a thin porous membrane. The extracorporeal membrane oxygenation machine market has a huge scope during the forecast period. The global extracorporeal membrane oxygenation machine market can be segmented based on component type application, modality and region

Depending on the component type the global extracorporeal membrane oxygenation machine market is segmented into pumps, oxygenators, heat exchangers, saturation monitors and others (Bladders, Cannulas). The pumps segment includes two main sub-segments viz. roller pumps and centrifugal pumps. The oxygenators segment is projected to be a highly attractive segment of the global extracorporeal membrane oxygenation machine market during the forecast period. The segment is anticipated to be expand at a CAGR of 5.7% during the forecast period. Increasing number of emerging players operating in the market for oxygenator manufacturing is expected to fuel the segment growth.

Based on application the global extracorporeal membrane oxygenation machine market is categorized into respiratory, cardiology and extracorporeal cardiopulmonary resuscitation. The cardiology segment is a rapid growing segment of the global extracorporeal membrane oxygenation machine market. Based on modality the extracorporeal membrane oxygenation machine market is classified into, venoarterial, venovenous and arteriovenous. Venoarterial is a rapidly growing segment driven by rise in prevalence of cardiovascular disease globally as well as improving health care infrastructure in developing countries.

Extracorporeal Membrane Oxygenation Machine Market: Geographical and Competitive Dynamics

Geographically, the global extracorporeal membrane oxygenation machine market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the extracorporeal membrane oxygenation machine market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies Terumo Corporation, Medtronic plc, Getinge AB, LivaNova PLC, Nipro Corporation, MicroPort Scientific Corporation, XENIOS AG, OriGen Biomedical, EUROSETS and Hemovent GmbH.

The global Extracorporeal Membrane Oxygenation Machine Market is segmented as follows:

Global Extracorporeal Membrane Oxygenation Machine Market, by Component type

  • Pumps
    • Roller Pumps
    • Centrifugal Pumps
  • Oxygenators
  • Heat Exchangers
  • Saturation Monitors
  • Others (Bladders, Cannulas)

Global Extracorporeal Membrane Oxygenation Machine Market, by Application

  • Respiratory
  • Cardiology
  • Extracorporeal Cardiopulmonary Resuscitation

Global Extracorporeal Membrane Oxygenation Machine Market, by Modality

  • Venoarterial
  • Venovenous
  • Arteriovenous

Global Extracorporeal Membrane Oxygenation Machine Market, by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Israel
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
.